Official Statistics

NI Sodium Valproate and Topiramate Monitoring Report to March 2026

Statistics on the number of patients, including females of child bearing age, prescribed either Sodium Valproate or Topiramate.

• From: HSC Business Services Organisation (Northern Ireland), Northern Ireland Statistics and Research Agency and Department of Health (Northern Ireland)
• Published: 28 May 2026

Applies to Northern Ireland

Documents

Northern Ireland Sodium Valproate Monitoring April 2019 to March 2026 tables

MS Excel Spreadsheet, 5.6 MB

Northern Ireland Topiramate Monitoring April 2023 to March 2026 tables

MS Excel Spreadsheet, 5.48 MB

Northern Ireland Sodium Valproate and Topiramate Monitoring Dashboard

https://datavis.nisra.gov.uk/bso/sodium-valproate-and-topiramate-monitoring-dashboard.html

Sodium Valproate & Topiramate Key Facts Summary March 2026

PDF, 585 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email BSO_PrimaryCare.Statistics@hscni.net. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents figures for males and females (including those of childbearing age) prescribed and dispensed Sodium Valproate or Topiramate in Northern Ireland. Broken down by age, gender and HSC Trust of residence, this report monitors prescribing of these medicines and helps support decision making for patient safety. An accompanying interactive dashboard has been produced which replaces charts previously contained within the main report.

Published 28 May 2026